Health economics of substance use disorder, HCV, and HIV treatment in the ERA of integrated health care

Active Project Grant Awarded Last action

Award ID
P30DA040500
Recipient
Awarding agency
Obligated
$42,128,701

Award facts

Assistance listing
93.279 Drug Use and Addiction Research Programs
Completion date 76% complete
Originally
Funding
  • $40,427,070.16 Federal
  • $1,701,631.00 Non-federal
Place of performance
New York, NY 10065, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment Health economics of substance use disorder, HCV, and HIV treatment: supporting financial sustainability, advanced methods, and knowledge translation - in the 10… $0
Amendment Health economics of substance use disorder, HCV, and HIV treatment: evaluating intervention outcomes for individuals, systems, and communities - overall project… $0
Amendment $0
Amendment Health economics of substance use disorder, HCV, and HIV treatment: supporting financial sustainability, advanced methods, and knowledge translation - in the 10… $2,173,314
Amendment Health economics of substance use disorder, HCV, and HIV treatment: evaluating intervention outcomes for individuals, systems, and communities - overall project… $2,173,314
Amendment $0
Amendment Health economics of substance use disorder, HCV, and HIV treatment: supporting financial sustainability, advanced methods, and knowledge translation - in the 10… $0
Amendment Health economics of substance use disorder, HCV, and HIV treatment: evaluating intervention outcomes for individuals, systems, and communities - overall project… $0
Amendment $2,270,589
Amendment $2,270,589
Amendment $0
Amendment $0
Amendment $0
Amendment Health economics of substance use disorder, HCV, and HIV treatment: supporting financial sustainability, advanced methods, and knowledge translation - in the 10… $0
Amendment Health economics of substance use disorder, HCV, and HIV treatment: evaluating intervention outcomes for individuals, systems, and communities - overall project… $0
Amendment Health economics of substance use disorder, HCV, and HIV treatment: supporting financial sustainability, advanced methods, and knowledge translation - in the 10… $0
Amendment $0
Amendment Health economics of substance use disorder, HCV, and HIV treatment: evaluating intervention outcomes for individuals, systems, and communities - overall project… $0
Amendment Health economics of substance use disorder, HCV, and HIV treatment: supporting financial sustainability, advanced methods, and knowledge translation - in the 10… $0
Amendment $1,564,216
Amendment $1,564,216
Amendment $1,564,216
Amendment $1,564,216
Amendment $1,564,216
Amendment -$73,352
Amendment -$73,352
Amendment $1,589,988
Amendment $1,589,988
Amendment Health economics of substance use disorder, HCV, and HIV treatment: evaluating intervention outcomes for individuals, systems, and communities - overall project… $1,589,988
Amendment -$42,108
Amendment $9,493
Amendment Health economics of substance use disorder, HCV, and HIV treatment: evaluating intervention outcomes for individuals, systems, and communities - overall project… $9,493
Amendment -$42,108
Amendment $9,493
Amendment -$42,108
Amendment Health economics of substance use disorder, HCV, and HIV treatment: evaluating intervention outcomes for individuals, systems, and communities - overall project… -$42,108
Amendment -$42,108
Amendment Health economics of substance use disorder, HCV, and HIV treatment: evaluating intervention outcomes for individuals, systems, and communities - overall project… -$42,108
Amendment $9,493
Amendment Health economics of substance use disorder, HCV, and HIV treatment: evaluating intervention outcomes for individuals, systems, and communities - overall project… $9,493
Amendment $73,352
Amendment Health economics of substance use disorder, HCV, and HIV treatment: evaluating intervention outcomes for individuals, systems, and communities - overall project… $73,352
Amendment $73,352
Amendment Health economics of substance use disorder, HCV, and HIV treatment: evaluating intervention outcomes for individuals, systems, and communities - overall project… $73,352
Amendment $73,352
Amendment Health economics of substance use disorder, HCV, and HIV treatment: evaluating intervention outcomes for individuals, systems, and communities - overall project… $73,352
Amendment $1,564,216
Amendment $1,564,216
Amendment Health economics of substance use disorder, HCV, and HIV treatment: evaluating intervention outcomes for individuals, systems, and communities - overall project… $1,564,216
Amendment $1,564,216
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

Subawards

Subrecipient Amount Awarded
New York University Jonathan Purtle, MPH, DrPH (0.85 academic months in year 1) Jonathan Purtle, MPH, DrPH is Associate Professor of Public Health Policy & Management and… $89,495
Boston Medical Center Corporation Project Title: Health Economics of Substance Use Disorder, HCV, and HIV Treatment: Supporting Financial Sustainability, Health Equity, and Knowledge Translation… $529,307
The Trustees Of The University Of Pennsylvania The subcontract PI, Dr. Kevin Lynch, PhD, in consultation with contact PI, Dr. Thomas Bottyan, MD, , shall conduct an exploratory statistical analysis on the… $672,916
Yale Univ Adati Tarfa, PharmD, MS, PhD, will serve as the Principal Investigator for the grant titled “Cost Analysis for a Retail Mobile Community Pharmacy… $24,340
University Of Connecticut Health Center Project Scope Dr. Sprague Martinez (10% calendar) will serve as an investigator for the Health Economics of Substance Use Disorder, HCV, and HIV Treatment:… $107,474
The Board Of Trustees Of The Leland Stanford Junior University The overall objective for this project is to evaluate the health and economic impacts of scaling long-acting injectable pre-exposure prophylaxis (LAI-PrEP)… $39,212
Boston Medical Center Corporation Boston Medical Center (BMC) will serve as a subcontract to Weill Cornell Medicine for a proposed renewal of “Health Economics of Substance Use Disorder, HCV,… $229,589
Trustees Of Boston University Jake Morgan, Ph.D. Dr. Morgan, an Assistant Professor of Health Law, Policy and Management at the Boston University School of Public Health serves as a… $298,686
Baystate Medical Center, Inc. Benjamin Bovell-Ammon, MD, MPH, Principal Investigator of this pilot project subaward, will conduct and disseminate the proposed research study on the… $19,960
University Of Washington The rapidly evolving healthcare environment necessitates a detailed understanding of the financial implications surrounding major health challenges. This… $20,000
Trustees Of Boston University Jake Morgan, Ph.D. Dr. Morgan, an Assistant Professor of Health Law, Policy and Management at the Boston University School of Public Health serves as a… $1,180,966
Boston Medical Center Corporation Benjamin P. Linas, MD, MPH will serve as Population Data and Modeling Core (PDMC) Director. He will be responsible for the overall direction of the Core… $1,206,874
University Of Miami Kathryn E. McCollister, Ph.D., PI. Annual support is requested for 1.98 calendar months of Dr. McCollister’s salary for year 3. Dr. McCollister will… $494,535
The Trustees Of The University Of Pennsylvania Dr. Meisel will serve as Dissemination & Policy Core Director. He will be responsible for the overall direction of the Core including translating and… $1,416,280
Nova Southeastern University, Inc. The proposed study aims to explore contextual factors related to the implementation of longacting injectable HIV PrEP. This will include 35 qualitative… $20,000
The Johns Hopkins University Aim 1: To translate and disseminate health economic research results to key stakeholders for substance use disorder treatment policy and HCV and HIV care for… $19,800
Brigham & Womens Hospital Inc. My project will investigate utilization of HCV testing, linkage, and treatment among a nationally representative cohort of children who were perinatally exposed… $20,000
Chestnut Health Systems Inc. Relevance Statements for Refinement of recovery utility weight estimation from the National Recovery Survey, PI: Castedo de Martell 3. Statement on relevance to… $20,000
Show all 18

Quick answers

Who received award P30DA040500?

P30DA040500 was awarded to Weill Medical College Of Cornell University by National Institute on Drug Abuse (National Institutes of Health) on July 15, 2015.

How much is award P30DA040500 worth?

$42,128,701 has been obligated on P30DA040500: $40,427,070 in federal funding and $1,701,631 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login